RU2016144340A3 - - Google Patents

Download PDF

Info

Publication number
RU2016144340A3
RU2016144340A3 RU2016144340A RU2016144340A RU2016144340A3 RU 2016144340 A3 RU2016144340 A3 RU 2016144340A3 RU 2016144340 A RU2016144340 A RU 2016144340A RU 2016144340 A RU2016144340 A RU 2016144340A RU 2016144340 A3 RU2016144340 A3 RU 2016144340A3
Authority
RU
Russia
Application number
RU2016144340A
Other languages
Russian (ru)
Other versions
RU2698330C2 (ru
RU2016144340A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016144340A publication Critical patent/RU2016144340A/ru
Publication of RU2016144340A3 publication Critical patent/RU2016144340A3/ru
Application granted granted Critical
Publication of RU2698330C2 publication Critical patent/RU2698330C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
RU2016144340A 2014-04-21 2014-04-21 Быстрое купирование двигательных флуктуаций при болезни паркинсона RU2698330C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/034778 WO2015163840A1 (en) 2014-04-21 2014-04-21 Rapid relief of motor fluctuations in parkinson's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2019126085A Division RU2019126085A (ru) 2019-08-19 2019-08-19 Быстрое купирование двигательных флуктуаций при болезни паркинсона

Publications (3)

Publication Number Publication Date
RU2016144340A RU2016144340A (ru) 2018-05-22
RU2016144340A3 true RU2016144340A3 (enExample) 2018-05-22
RU2698330C2 RU2698330C2 (ru) 2019-08-26

Family

ID=54332876

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016144340A RU2698330C2 (ru) 2014-04-21 2014-04-21 Быстрое купирование двигательных флуктуаций при болезни паркинсона

Country Status (14)

Country Link
US (2) US20170296498A1 (enExample)
EP (2) EP3831375A1 (enExample)
JP (1) JP2017513866A (enExample)
KR (2) KR20170008754A (enExample)
CN (2) CN106659685B (enExample)
AU (2) AU2014391721B2 (enExample)
BR (1) BR112016024502A8 (enExample)
CA (1) CA2946165C (enExample)
IL (2) IL309959A (enExample)
MX (1) MX2016013741A (enExample)
RU (1) RU2698330C2 (enExample)
SG (1) SG11201608608PA (enExample)
WO (1) WO2015163840A1 (enExample)
ZA (1) ZA201607833B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015010601B1 (pt) 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
EP3735298A4 (en) * 2018-01-05 2021-10-06 Impel Neuropharma Inc. INTRANASAL ADMINISTRATION OF LEVODOPA POWDER BY N BY AN OLFACTORIC PRECISION DEVICE
JP2021532098A (ja) 2018-07-19 2021-11-25 インペル ニューロファーマ インコーポレイテッド パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US6858199B1 (en) 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
SI2630954T1 (sl) * 2002-03-20 2017-02-28 Civitas Therapeutics, Inc. Pulmonalno dovajanje za levodopo
AR044007A1 (es) * 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
US8496002B2 (en) 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
GB2454480A (en) * 2007-11-07 2009-05-13 Vectura Group Plc Pulmonary inhalation of levodopa containing compositions in the treatment of Parkinsons disease and other central nervous system disorders
WO2010000763A2 (en) * 2008-06-30 2010-01-07 Novartis Ag Combination products
US8399513B2 (en) * 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
TW201304822A (zh) * 2010-11-15 2013-02-01 Vectura Ltd 組成物及用途
RU2685718C2 (ru) * 2012-10-22 2019-04-23 Сивитас Терапьютикс, Инк. Лекарственные формы леводопы для быстрого купирования болезни паркинсона
US8545878B1 (en) * 2012-11-09 2013-10-01 Civitas Therapeutics, Inc. Capsules containing high doses of levodopa for pulmonary use

Also Published As

Publication number Publication date
WO2015163840A1 (en) 2015-10-29
EP3134077A4 (en) 2017-12-20
SG11201608608PA (en) 2016-11-29
MX2016013741A (es) 2017-04-06
RU2698330C2 (ru) 2019-08-26
US20170296498A1 (en) 2017-10-19
RU2016144340A (ru) 2018-05-22
ZA201607833B (en) 2018-08-29
CA2946165C (en) 2022-10-18
AU2020239754B2 (en) 2022-06-23
BR112016024502A8 (pt) 2021-06-29
AU2020239754A1 (en) 2021-01-14
KR20170008754A (ko) 2017-01-24
CA2946165A1 (en) 2015-10-29
AU2014391721B2 (en) 2020-07-16
EP3134077A1 (en) 2017-03-01
JP2017513866A (ja) 2017-06-01
IL248445A0 (en) 2016-12-29
AU2014391721A1 (en) 2016-11-03
US20230053976A1 (en) 2023-02-23
CN106659685B (zh) 2021-02-05
BR112016024502A2 (pt) 2017-08-15
IL309959A (en) 2024-03-01
CN106659685A (zh) 2017-05-10
KR20210144946A (ko) 2021-11-30
CN113209055A (zh) 2021-08-06
EP3831375A1 (en) 2021-06-09

Similar Documents

Publication Publication Date Title
BR112016017979A2 (enExample)
BR112016016761A2 (enExample)
BR112016015519A2 (enExample)
BR112016015890A2 (enExample)
BR112016003131A2 (enExample)
BR112016016490A2 (enExample)
BR112016016546A2 (enExample)
BR112016014949A2 (enExample)
BR112016018264A2 (enExample)
BR112016017103A2 (enExample)
BR112016017031A2 (enExample)
BR112016016924A2 (enExample)
BR112016016421A2 (enExample)
BR112016016106A2 (enExample)
BR112016012568A2 (enExample)
BR112016016558A2 (enExample)
BR112016015798A2 (enExample)
BR112016021559A2 (enExample)
BR112016017960A2 (enExample)
BR112016015915A2 (enExample)
BR112016018252A2 (enExample)
BR112016017216A2 (enExample)
BR112016016468A2 (enExample)
BR112016016389A2 (enExample)
BR112016017356A2 (enExample)